These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5245306)
21. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma. Ditzel J; Jordal R; Riskaer N Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976 [No Abstract] [Full Text] [Related]
22. The urinary excretion of hydroxyproline in metabolic disorders of connective tissue and bone. Birkenhäger JC Folia Med Neerl; 1970; 13(2):79-87. PubMed ID: 5422995 [No Abstract] [Full Text] [Related]
23. Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer. Niell HB; Palmieri GM; Neely CL; Maxwell TA; Hopkins SC; Soloway MS Arch Intern Med; 1983 Oct; 143(10):1925-7. PubMed ID: 6625779 [TBL] [Abstract][Full Text] [Related]
24. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism. Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935 [TBL] [Abstract][Full Text] [Related]
25. The determination of urinary 3-trans-hydroxyproline (3 OHP). I. Normal values in school children and adults. Weiss MT; Weninger M; Häusler J; Lubec G Padiatr Padol; 1988; 23(1):9-14. PubMed ID: 3387116 [TBL] [Abstract][Full Text] [Related]
26. [Findings on total hydroxyproline excretion in patients with scoliosis]. Agostini S; Scalella P; Fabris D Clin Ortop; 1974; 25(4):205-8. PubMed ID: 4471240 [TBL] [Abstract][Full Text] [Related]
27. [Use of urinary hydroxyproline elimination in the detection of bone metastases secondary to prostatic carcinoma]. de la Peña J; Cárcamo P; Martínez ME; Martínez-Piñeiro JA Actas Urol Esp; 1983; 7(3):199-204. PubMed ID: 6624563 [No Abstract] [Full Text] [Related]
33. [Hydroxyproline in generalized bone diseases]. Czitober H; Raab W Dtsch Med J; 1970 Jun; 21(12):857-64. PubMed ID: 5512354 [No Abstract] [Full Text] [Related]
34. Clinical applications of urinary hydroxyproline determination. Laitinen O Acta Med Scand Suppl; 1975; 577():1-57. PubMed ID: 1057370 [No Abstract] [Full Text] [Related]
35. Urinary hydroxyproline excretion in patients with breast cancer. Cuschieri A; Felgate R Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876 [No Abstract] [Full Text] [Related]
36. [The influence of diet on the urinary excretion of total, free and conjugated non-dialysable hydroxyproline in the normal adult (author's transl)]. Pilonchery G; Finck C; Minaire P; Messy P; Revol A Ann Biol Clin (Paris); 1982; 40(1):17-22. PubMed ID: 7081785 [TBL] [Abstract][Full Text] [Related]
37. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321 [TBL] [Abstract][Full Text] [Related]
38. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. III. Urinary hydroxyproline and glycosaminoglycan excretion following bone fractures treated in different ways. Kustos G; Klujber L; Weisenbach J; Szemlédy F Acta Chir Acad Sci Hung; 1979; 20(1):91-101. PubMed ID: 554383 [TBL] [Abstract][Full Text] [Related]
39. [The clinical significance of urinary hydroxyproline determinations (author's transl)]. Raab W Z Klin Chem Klin Biochem; 1972 May; 10(5):195-206. PubMed ID: 4219249 [No Abstract] [Full Text] [Related]
40. [Detection of bone metastases using hydroxyproline excretion]. Knorr A; Engelmann U; Gross C; Friedrich S Radiobiol Radiother (Berl); 1986; 27(1):31-4. PubMed ID: 3704125 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]